---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-120365"
form_type: "8-K"
ticker: "SGMT"
cik: "0001400118"
company_name: "Sagimet Biosciences Inc."
filed_at: "2023-11-21T23:59:59+00:00"
generated_at: "2026-06-07T22:35:37.078147+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sagimet Biosciences grants RSUs to executives post-IPO; CEO Happel receives 624,910 units

## Summary
- Board approved RSU grants: CEO David Happel (624,910), Eduardo Martins (89,570), George Kemble (150,750).
- RSUs vest 25% on first anniversary of IPO closing, remainder over three years, subject to continued service.
- Compensation Committee engaged Compensia to align executive compensation with public-company peers.

## SEC filing metadata
- accession: 0001104659-23-120365
- form_type: 8-K
- ticker: SGMT
- cik: 0001400118
- company_name: Sagimet Biosciences Inc.
- filed_at: 2023-11-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1400118/000110465923120365/0001104659-23-120365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1400118/000110465923120365/tm2331242d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-120365
- JSON: https://secwatch.observer/filing/0001104659-23-120365.json
- Plain text: https://secwatch.observer/filing/0001104659-23-120365.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.